Blood Pressure Control May Help Mitigate Dementia Risk From Hypertension
Researchers sought to assess the age at which the population attributable fraction of dementia from hypertension would be the highest.
Diagnosis & Disease Information
Physical Activity Levels in Adulthood Improve Cognition Later in Life
Researchers sought to assess how timing, frequency, and maintenance of physical activity in adulthood, over the span of 30 years, is associated with cognitive function later in life.
Why Women May Have a Higher Risk of Developing Dementia Than Men
In an international meta-analysis, researchers evaluated sex differences in all-cause dementia risk across diverse ethno-regional groups.
Common Viruses May Increase Long-Term Risk for Neurodegenerative Diseases
Researchers sought to examine potential associations between viral exposures and neurodegenerative disease risk.
Aducanumab, Lecanemab for Early AD: The Clinical Trials That Led to FDA Approval
These are the clinical trials that led to the FDA’s approval of aducanumab and lecanemab for early AD, plus, the concerns that loom.
Education May Predict Dementia Risk Among Centenarians and Near-Centenarians
In a meta-analysis, researchers estimated the prevalence of dementia in a centenarian and near-centenarian population and identified the risk and protective factors for dementia.
Vitamin D Levels in the Brain Correlate With Dementia Risk in Older Adults
Researchers sought to analyze brain concentrations of vitamin D and assess whether there were any associations with cognitive and neuropathology outcomes.
Vitamin D Deficiency Linked to Neurologic Disorders
Research findings support the use of vitamin D supplementation to help slow cognitive decline in Alzheimer dementia and reduce Parkinson disease symptom severity.
Anemia Increases Dementia Risk in CKD
The association is revealed in a study of more 444,000 US veterans with new-onset chronic kidney disease.
Noradrenergic Drugs Improve Cognition, Apathy in Alzheimer Disease
Researchers sought to evaluate the efficacy of noradrenergic drugs in the improvement of neuropsychiatric and cognitive symptoms in individuals with AD.
- Loading...
Loading...
Loading... 
Loading...